You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Myelomonocytic Leukemia (CML)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Active, not recruiting
  • Chronic Myelomonocytic Leukemia-0
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2023

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

Not yet recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
Oct 20, 2022

Chronic Myeloid Leukemia Trial in France (Venetoclax)

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Amiens, France
  • +14 more
Mar 3, 2023

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

Recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • (no location specified)
Jul 29, 2022

Concomitant Medications at CML Diagnosis

Completed
  • Chronic Myeloid Leukemia
  • the prevalence of comorbid conditions
  • (no location specified)
Sep 16, 2023

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Myeloid Leukemia (CML) Trial in France

Recruiting
  • Chronic Myeloid Leukemia (CML)
    • Annecy, France
    • +11 more
    Jul 18, 2023

    According to Molecular Identification at Diagnosis

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Next Generation Sequencing (DNA and RNA)
    • (no location specified)
    Oct 28, 2022

    Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Chronic Myelomonocytic Leukemia Trial

    Recruiting
    • Recurrent Chronic Myelomonocytic Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 21, 2022